Company / Shareholders' Equity
Cardlytics, Inc. Shareholders' Equity History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Shareholders' Equity
-$6.5M
FY2025
5-year range
-$6.5M / $157.2M
FY2021-FY2025
Trend
-109.3%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Cardlytics, Inc. reports negative total equity of -$7M in FY2025. Negative equity can occur when accumulated losses exceed contributed capital, as reported in the balance sheet from the SEC filing.
Based on SEC 10-K filings.
-$7M in FY2025.
Declined from $135M to -$7M over the past 2 years.
Shareholders' Equity over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- Cardlytics, Inc.'s shareholders' equity has declined for 3 consecutive years.
- In FY2025, shareholders' equity decreased 109.3% year-over-year.
- Peak shareholders' equity was recorded in FY2022.
- Lowest shareholders' equity in the period was in FY2018.
Company context
Key Data Points
- Altman Z-Score -4.32 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Shareholders' EquityValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$6.5M | -109.3% |
| FY2024 | $70.0M | -48.1% |
| FY2023 | $134.8M | -14.2% |
| FY2022 | $157.2M | +202.4% |
| FY2021 | $52.0M | +0.0% |
| FY2020 | $52.0M | +124.9% |
| FY2019 | -$208.7M | +3.8% |
| FY2018 | -$216.8M | - |
As of FY2025 · SEC 10-K Annual Filings · Updated Jun 24, 2026